Important information

Directions

Read user guide before use.

Legal Disclaimer

Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.

Disclaimer: While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Amazon.com assumes no liability for inaccuracies or misstatements about products.


Product Description

Product Description

INDICATIONS: Contour Next 7278 Blood Glucose Test Strips CONTOUR NEXT blood glucose test strips offer a simple solution for your testing needs with No Coding technology, proven accuracy, fast test time, and small blood sample. Second-Chance Sampling allows you to apply more blood which may help to prevent wasting test strips and may help to save money. Established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Already including the world‐renowned CONTOUR range of blood glucose monitoring systems, we are committed to adding more innovative and life­changing products to our portfolio. Ascensia, the Ascensia Diabetes Care logo, Contour, Second-Chance, the Second-Chance logo, No Coding, the No Coding logo are trademarks and or registered trademarks of Ascensia Diabetes Care. Do not use during or soon after Xylose absorption testing. Xylose in the blood will cause interference. References: 1. Christiansen, M. P. (2017). A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology, 11(3), 567-573. DOI: 10.1177/1932296817691301. 2. Bernstein, R. et al. (2013). A New Test Strip Technology Platform for Self-Monitoring of Blood Glucose. Journal of Diabetes Science and Technology, 7(5), 1386-1399. 3. Ascensia Diabetes Care. Data on File. Second Chance Sampling Research Topline Report, (May 2015). A 15-minute online study was conducted among people with diabetes (PWDs) and diabetes nurse educators (DNEs) in the US, UK and DE. PWDs and Pharmacists were the target in Canada. Hall & Partners. 4. Goldy, A. et al. (2014). Interference Evaluation of the CONTOURNEXT Test Strip. Poster presented at Advances Technologies & Treatment for Diabetes (ATTD), February 5-8, 2014. Vienna, Australia


From the Manufacturer

Established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Already including the world‐renowned CONTOUR range of blood glucose monitoring systems, we are committed to adding more innovative and life-changing products to our portfolio. Ascensia, the Ascensia Diabetes Care logo, Contour, Second-Chance, the Second-Chance logo, No Coding, the No Coding logo are trademarks and or registered trademarks of Ascensia Diabetes Care. *Do not use during or soon after Xylose absorption testing. Xylose in the blood will cause interference. References: 1. Christiansen, M. P. (2017). A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology, 11(3), 567-573. DOI: 10.1177/1932296817691301. 2. Bernstein, R. et al. (2013). A New Test Strip Technology Platform for Self-Monitoring of Blood Glucose. Journal of Diabetes Science and Technology, 7(5), 1386-1399. 3. Richardson J et al, Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the Diabetes Technology Meeting (DTM) 2020, Maryland, USA. 4. Goldy, A. et al. (2014). Interference Evaluation of the CONTOUR®NEXT Test Strip. Poster presented at Advances Technologies & Treatment for Diabetes (ATTD), February 5-8, 2014. Vienna, Australia


Manufacturer Contact Information

main banner